Bing

SEARCH HISTORY

La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the “Company” or “La Jolla”), a leader in the development of therapeutics targeting significant unmet life-threatening diseases, today announced the closing of its underwritten public offering of ...
Reuters · 7/28/2014
Common Stock, $0.0001 par value; 100,000,000 shares authorized, 15,250,840 and 15,225,980 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively 2 2 Series C-12 Convertible Preferred Stock, $0.0001 par value; 11,000 …
Market Watch · 4/29/2015
SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (OTCBB:LJPC), a biopharmaceutical company dedicated to improving and preserving human life by acquiring and developing innovative pharmaceutical products, reported today that its …
Business Wire · 4/13/2011
La Jolla Pharmaceutical Company (NASDAQ: LJPC) shares touched a new 52-week high of $28.47. La Jolla Pharmaceutical shares have jumped 221.01 percent over the past 52 weeks, while the S&P 500 index has gained 5.01 percent in the same period.
Benzinga · ByLisa Levin · 7/6/2015
SAN DIEGO, CA--(Marketwired - Jan 29, 2014) - La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the "Company" or "La Jolla"), a leader in the development of therapeutics targeting significant unmet life-threatening diseases, today announced that it has ...
marketwired.com · 1/29/2014
Boston, MA 09/29/2014 (wallstreetpr) – One of the major shareholder and Director of La Jolla Pharmaceutical Company (NASDAQ ... However, it does not mean that the stock has upside potential rewards in the near-term.
wallstreetpr.com · 9/29/2014
LPJC, La Jolla Pharmaceutical Company (NASDAQ: LJPC) has entered a definitive merger ... to assume the name of Adamis Pharmaceuticals Corporation. Simply Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on …
TransWorldNews · 12/9/2009
News about Sunshine Biopharma Inc. Point Roberts, WA - January 15, 2013 (Investorideas.com Newswire) Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues an alert for investors …
investorideas.com · 1/15/2013
... 10% owner of La Jolla Pharmaceutical Co(LJPC), bought 220,000 shares of LJPC at the price of $22.23 with a total cost of $4,890,600. After that buy, the price of the stock rose by 8%. The company has an insider ownership of 11% and an Institutional ...
Guru Focus · 6/29/2015
IMNP closed Monday's trading 0.56% higher at $1.78. In after-hours, the stock was up 8.99% to $1.94. La Jolla Pharmaceutical Co. (LJPC) has a couple of clinical trial events lined up for the coming months. In the first quarter of 2015, La Jolla plans to ...
Realtime Business News · 3/17/2015